3rd Circ. Backs Nix Of Pharmacies' Claim In Lipitor MDL
The Third Circuit declined Wednesday to revive claims by several pharmacies that a settlement between Pfizer Inc. and Ranbaxy Inc. over the popular anti-cholesterol medication Lipitor ran afoul of antitrust laws,...To view the full article, register now.
Already a subscriber? Click here to view full article